FDA Finalizes Stance On Obstructed Pharma Inspections
The U.S. Food and Drug Administration on Tuesday finalized new policies on oversight of drug manufacturing plants, adopting an aggressive stance on its photography powers while also describing situations in which...To view the full article, register now.
Already a subscriber? Click here to view full article